Table 1.
Characteristics of eleven trials of early enteral feeding after elective gastrointestinal surgery
No of patients
|
Type of feed | Route of feeding | Pathology (%)
|
Site of surgery (%)
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
Active | Control | Malignant | Benign | Upper | Lower | Hepatobiliary | ||||
Schroeder et al, 199113 | 16 | 16 | Standard | NJ | NR | NR | 0 | 100 | 0 | |
Sagar et al, 197920 | 15 | 15 | Elemental | NJ | NR | NR | 27 | 73 | 0 | |
Binderow et al, 199421 | 32 | 32 | Oral | Oral | NR | NR | 0 | 100 | 0 | |
Reissman et al, 199522 | 80 | 81 | Oral | Oral | NR | NR | 0 | 100 | 0 | |
Carr et al, 199623 | 14 | 14 | Standard | NJ | NR | NR | NR | NR | NR | |
Beier-Holgersen et al, 199624 | 30 | 30 | Standard | ND | 65 | 35 | 13 | 87 | 0 | |
Ortiz et al, 199625 | 95 | 95 | Oral | Oral | 87 | 23 | 0 | 100 | 0 | |
Heslin et al, 199726 | 97 | 98 | Immune enhancing | J | 93 | 7 | 51 | 0 | 49 | |
Hartsell et al, 199727 | 29 | 29 | Standard | Oral | 64 | 28 | 0 | 100 | 0 | |
Watters et al, 199728 | 15 | 16 | Standard | J | 93 | 7 | 96 | 0 | 4 | |
Stewart et al, 199829 | 40 | 40 | Oral | Oral | NR | NR | 0 | 100 | 0 |
NJ=nasojejunal tube, ND=nasoduodenal tube, J=jejunostomy, NR=not reported.